N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide)

C122H139N35O10S5 — CID 158688486

IUPACN-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide)
SMILESCc1cn(-c2ccc(Nc3ncc(C)c(Nc4cccc(S(=O)(=O)NC(C)(C)C)c4)n3)cc2)cn1.Cc1cnc(Nc2ccc(-n3cccn3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cc1cnc(Nc2ccc(-n3cccn3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cc1cnc(Nc2ccc(-n3ccnc3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cc1cnc(Nc2ccc(-n3ccnc3C)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1
InChIInChI=1S/2C25H29N7O2S.3C24H27N7O2S/c1-17-14-26-24(29-19-9-11-21(12-10-19)32-15-18(2)27-16-32)30-23(17)28-20-7-6-8-22(13-20)35(33,34)31-25(3,4)5;1-17-16-27-24(29-19-9-11-21(12-10-19)32-14-13-26-18(32)2)30-23(17)28-20-7-6-8-22(15-20)35(33,34)31-25(3,4)5;2*1-17-16-25-23(28-18-9-11-20(12-10-18)31-14-6-13-26-31)29-22(17)27-19-7-5-8-21(15-19)34(32,33)30-24(2,3)4;1-17-15-26-23(28-18-8-10-20(11-9-18)31-13-12-25-16-31)29-22(17)27-19-6-5-7-21(14-19)34(32,33)30-24(2,3)4/h6-16,31H,1-5H3,(H2,26,28,29,30);6-16,31H,1-5H3,(H2,27,28,29,30);2*5-16,30H,1-4H3,(H2,25,27,28,29);5-16,30H,1-4H3,(H2,26,27,28,29)
InChIKeyIGASUJMFQTVCON-UHFFFAOYSA-N
MW2416.02 g/mol
LogP23.29
Rot. Bonds35

About N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide)

N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide) (PubChem CID 158688486) has the molecular formula C122H139N35O10S5 and a molecular weight of 2416.02 g/mol. Its IUPAC name is N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide).

Molecular Properties

Compound NameN-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide)
PubChem CID158688486
Molecular FormulaC122H139N35O10S5
Molecular Weight2416.02 g/mol
Exact Mass2414.00
IUPAC NameN-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide)
SMILESCc1cn(-c2ccc(Nc3ncc(C)c(Nc4cccc(S(=O)(=O)NC(C)(C)C)c4)n3)cc2)cn1.Cc1cnc(Nc2ccc(-n3cccn3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cc1cnc(Nc2ccc(-n3cccn3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cc1cnc(Nc2ccc(-n3ccnc3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cc1cnc(Nc2ccc(-n3ccnc3C)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1
InChIInChI=1S/2C25H29N7O2S.3C24H27N7O2S/c1-17-14-26-24(29-19-9-11-21(12-10-19)32-15-18(2)27-16-32)30-23(17)28-20-7-6-8-22(13-20)35(33,34)31-25(3,4)5;1-17-16-27-24(29-19-9-11-21(12-10-19)32-14-13-26-18(32)2)30-23(17)28-20-7-6-8-22(15-20)35(33,34)31-25(3,4)5;2*1-17-16-25-23(28-18-9-11-20(12-10-18)31-14-6-13-26-31)29-22(17)27-19-7-5-8-21(15-19)34(32,33)30-24(2,3)4;1-17-15-26-23(28-18-8-10-20(11-9-18)31-13-12-25-16-31)29-22(17)27-19-6-5-7-21(14-19)34(32,33)30-24(2,3)4/h6-16,31H,1-5H3,(H2,26,28,29,30);6-16,31H,1-5H3,(H2,27,28,29,30);2*5-16,30H,1-4H3,(H2,25,27,28,29);5-16,30H,1-4H3,(H2,26,27,28,29)
InChIKeyIGASUJMFQTVCON-UHFFFAOYSA-N
XLogP23.29
TPSA569.15 Ų
H-Bond Donors15
H-Bond Acceptors40
Rotatable Bonds35
Heavy Atoms172
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002416.02
LogP ≤ 523.29
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1040

Analyze N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide) with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide)?
The IUPAC name of N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide) (CID 158688486) is N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide).
What is the SMILES notation for N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide)?
The canonical SMILES for N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide) is Cc1cn(-c2ccc(Nc3ncc(C)c(Nc4cccc(S(=O)(=O)NC(C)(C)C)c4)n3)cc2)cn1.Cc1cnc(Nc2ccc(-n3cccn3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cc1cnc(Nc2ccc(-n3cccn3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cc1cnc(Nc2ccc(-n3ccnc3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.Cc1cnc(Nc2ccc(-n3ccnc3C)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1.
What is the InChIKey of N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide)?
The InChIKey is IGASUJMFQTVCON-UHFFFAOYSA-N. The full InChI is InChI=1S/2C25H29N7O2S.3C24H27N7O2S/c1-17-14-26-24(29-19-9-11-21(12-10-19)32-15-18(2)27-16-32)30-23(17)28-20-7-6-8-22(13-20)35(33,34)31-25(3,4)5;1-17-16-27-24(29-19-9-11-21(12-10-19)32-14-13-26-18(32)2)30-23(17)28-20-7-6-8-22(15-20)35(33,34)31-25(3,4)5;2*1-17-16-25-23(28-18-9-11-20(12-10-18)31-14-6-13-26-31)29-22(17)27-19-7-5-8-21(15-19)34(32,33)30-24(2,3)4;1-17-15-26-23(28-18-8-10-20(11-9-18)31-13-12-25-16-31)29-22(17)27-19-6-5-7-21(14-19)34(32,33)30-24(2,3)4/h6-16,31H,1-5H3,(H2,26,28,29,30);6-16,31H,1-5H3,(H2,27,28,29,30);2*5-16,30H,1-4H3,(H2,25,27,28,29);5-16,30H,1-4H3,(H2,26,27,28,29).
What are the key properties of N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide)?
N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide) has a molecular weight of 2416.02 g/mol, XLogP of 23.29, 35 rotatable bonds, 15 hydrogen bond donors, and 40 hydrogen bond acceptors.
Where does this data come from?
All data for N-tert-butyl-3-[[2-(4-imidazol-1-ylanilino)-5-methylpyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(2-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;N-tert-butyl-3-[[5-methyl-2-[4-(4-methylimidazol-1-yl)anilino]pyrimidin-4-yl]amino]benzenesulfonamide;bis(N-tert-butyl-3-[[5-methyl-2-(4-pyrazol-1-ylanilino)pyrimidin-4-yl]amino]benzenesulfonamide) is sourced from PubChem (CID 158688486), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).